Search research articles
Contact Us
Filters
Showing results (311-320 of 314) with videos related to
Page
of 32
Sort By:
You have reached the last page of results.
This site can display upto 314 results.
Biorxiv : the Preprint Server for Biology
|
October 24, 2023
Spiral NeuroString: High-Density Soft Bioelectronic Fibers for Multimodal Sensing and Stimulation
Muhammad Khatib, Eric Tianjiao Zhao, Shiyuan Wei, et al.
Nature
|
September 17, 2025
High-density soft bioelectronic fibres for multimodal sensing and stimulation
Muhammad Khatib, Eric Tianjiao Zhao, Shiyuan Wei, et al.
Quantitative Imaging in Medicine and Surgery
|
January 15, 2024
Chinese expert consensus on imaging diagnosis of drug-resistant pulmonary tuberculosis
Chuan-Jun Xu, Pu-Xuan Lu, Chun-Hua Li, et al.
Cancer Communications (London, England)
|
June 29, 2021
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first-line treatment for Chinese patients with unresectable, metastatic, or recurrent non-squamous non-small-cell lung cancer: A multicenter, randomized, double-blinded, phase III trial
Yuankai Shi, Kaijian Lei, Yuming Jia, et al.
Page
of 32
Search research articles
Search
Showing results (311-320 of 314) with videos related to
Sort By:
Page
of 32
You have reached the last page of results.
This site can display upto 314 results.
Biorxiv : the Preprint Server for Biology
|
October 24, 2023
Spiral NeuroString: High-Density Soft Bioelectronic Fibers for Multimodal Sensing and Stimulation
Muhammad Khatib, Eric Tianjiao Zhao, Shiyuan Wei, et al.
Nature
|
September 17, 2025
High-density soft bioelectronic fibres for multimodal sensing and stimulation
Muhammad Khatib, Eric Tianjiao Zhao, Shiyuan Wei, et al.
Quantitative Imaging in Medicine and Surgery
|
January 15, 2024
Chinese expert consensus on imaging diagnosis of drug-resistant pulmonary tuberculosis
Chuan-Jun Xu, Pu-Xuan Lu, Chun-Hua Li, et al.
Cancer Communications (London, England)
|
June 29, 2021
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first-line treatment for Chinese patients with unresectable, metastatic, or recurrent non-squamous non-small-cell lung cancer: A multicenter, randomized, double-blinded, phase III trial
Yuankai Shi, Kaijian Lei, Yuming Jia, et al.
Page
of 32